- Trials with a EudraCT protocol (35)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
35 result(s) found for: Reflection.
Displaying page 1 of 2.
EudraCT Number: 2009-014643-36 | Sponsor Protocol Number: MeBe/08/NEB-MICR/001 | Start Date*: 2010-04-23 |
Sponsor Name:MENARINI Benelux NV/SA | ||
Full Title: Effects Of The Administration Of Nebivolol Versus Carvedilol On Microcirculatory Endothelial Function, Arterial Stiffness And Wave Reflection In Healthy Volunteers” (NeCaMic-study) | ||
Medical condition: Microcirculatory Endothelial Function, Arterial Stiffness And Wave Reflection | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: BE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2020-000604-11 | Sponsor Protocol Number: PIPAC | Start Date*: 2020-07-29 | |||||||||||
Sponsor Name:FONDAZIONE IRCCS "ISTITUTO NAZIONALE DEI TUMORI" | |||||||||||||
Full Title: Phase II study of adjuvant pressurized intraperitoneal aerosol chemotherapy (PIPAC) for the prevention of peritoneal metastases after curative-intent surgery for high-risk colorectal cancer. | |||||||||||||
Medical condition: Patients with colon adenocarcinoma (proximal to peritoneal reflection) in stage pT4a / b, N0-2, M0, or with primitive perforated tumor undergoing curative surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001568-29 | Sponsor Protocol Number: ras-blok | Start Date*: 2005-06-22 |
Sponsor Name:Dept. of Nephrology | ||
Full Title: Pulsbølgehastighed og pulsbølgemorfologi hos patienter med kronisk nyreinsufficiens: Effekten af blokade af renin-angiotensinsystemet. | ||
Medical condition: Kronisk nyreinsufficiens | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000178-24 | Sponsor Protocol Number: W2021.040 | Start Date*: 2023-10-20 |
Sponsor Name: | ||
Full Title: Active vitamin D for secondary hyperparathyroidism after bariatric surgery: a multicenter randomized controlled trial. | ||
Medical condition: patients with secondary hyperparathyroidism after Roux-en-Y gastric bypass surgery (RYGB). | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004169-14 | Sponsor Protocol Number: BMS-MB102-210 | Start Date*: 2014-02-07 | |||||||||||
Sponsor Name:University Hospital Erlangen | |||||||||||||
Full Title: Randomized, placebo controlled, crossover clinical study to analyse the effect of dapagliflozin on microvascular and macrovascular circulation and total body sodium content | |||||||||||||
Medical condition: Type 2 diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002583-80 | Sponsor Protocol Number: 38814 | Start Date*: 2013-09-06 | |||||||||||
Sponsor Name:Department of Dermatology, Bispebjerg University Hospital | |||||||||||||
Full Title: Treatment of Actinic Keratoses with Ingenol Mebutate and topical glucocorticosteroid - a safety study | |||||||||||||
Medical condition: Actinic Keratoses | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000629-32 | Sponsor Protocol Number: MO17092 | Start Date*: 2006-12-21 |
Sponsor Name:University of Oxford | ||
Full Title: Multicentre international study of capecitabine ± bevacizumab as adjuvant treatment of colorectal cancer | ||
Medical condition: adjuvant treatment of colorectal cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SI (Completed) AT (Completed) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-006072-38 | Sponsor Protocol Number: HEPATICA | Start Date*: 2007-11-07 |
Sponsor Name:the Dutch Colorectal Cancer Group | ||
Full Title: A Randomised Two Arm Phase III Study in Patients Post Radical Resection of Liver Metastasis of Colorectal Cancer to Investigate Bevacizumab (q3w) in Combination With Capecitabine Plus Elaoxantin (X... | ||
Medical condition: Liver metastatis of colorectal cancer. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001825-29 | Sponsor Protocol Number: ANA-COVID-GEAS | Start Date*: 2020-04-28 |
Sponsor Name:NAVARRABIOMED - FUNDACIÓN MIGUEL SERVET | ||
Full Title: CLINICAL TRIAL OF THE USE OF ANAKINRA (ANTI IL-1) IN CYTOKINE STORM SYNDROME (CSS) SECONDARY TO COVID-19 | ||
Medical condition: Hyperinflammation and respiratory distress in patients with SARS- CoV-2 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002225-29 | Sponsor Protocol Number: AntagoBrad-Cov | Start Date*: 2020-11-12 | ||||||||||||||||
Sponsor Name:Groupement de Coopération Sanitaire Ramsay Générale de Santé pour l’Enseignement et la Recherche | ||||||||||||||||||
Full Title: Evaluation of the effects of bradykinin antagonists on pulmonary manifestations of COVID-19 infections. | ||||||||||||||||||
Medical condition: COVID positive patients with respiratory impairment | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003053-34 | Sponsor Protocol Number: CRC2014EMPA | Start Date*: 2015-02-24 | |||||||||||
Sponsor Name:IPPMed – Institut für Pharmakologie und Präventive Medizin GmbH | |||||||||||||
Full Title: Randomized, double-blind, placebo controlled, crossover clinical study to analyse the effect of empagliflozin on microvascular circulation | |||||||||||||
Medical condition: Type 2 diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001858-90 | Sponsor Protocol Number: EORTC 40012 | Start Date*: 2004-12-30 | |||||||||||
Sponsor Name:EORTC | |||||||||||||
Full Title: Randomised Phase III Intergroup Trial in Resected Stage 2 (Dukes B) Colon Cancer : 6-month Infusional 5FU-CPT11 (+/- Folinic Acid) versus Observation. Determination of Biologic Predictive and Respo... | |||||||||||||
Medical condition: Resected Stage 2 (Dukes B) Colon Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) HU (Completed) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000715-26 | Sponsor Protocol Number: BO17920 | Start Date*: 2005-02-02 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd. | |||||||||||||
Full Title: A Randomized, Three Arm Multinational Phase III Study to Investigate Bevacizumab (q3w or q2w) in Combination With Either Intermittent Capecitabine Plus Oxaliplatin (XELOX) (q3w) or Fluorouracil/ Le... | |||||||||||||
Medical condition: Adjuvant treatment for patients who have undergone surgery for Colon cancer, AJCC/UICC high-risk Stage II & stage III | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) SE (Completed) DE (Completed) HU (Completed) GB (Completed) CZ (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002074-32 | Sponsor Protocol Number: IFOM-CPT005/2019/PO004 | Start Date*: 2020-02-11 | |||||||||||
Sponsor Name:IFOM - Istituto FIRC di Oncologia Molecolare | |||||||||||||
Full Title: POST-SURGICAL LIQUID BIOPSY-GUIDED TREATMENT OF STAGE III AND HIGH-RISK STAGE II COLON CANCER PATIENTS | |||||||||||||
Medical condition: Stage III and high-risk stage II colon cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001491-29 | Sponsor Protocol Number: Prodige52–UCGI29 | Start Date*: 2016-10-13 | |||||||||||
Sponsor Name:UNICANCER | |||||||||||||
Full Title: A Phase III, Randomised, international trial comparing mFOLFIRINOX triplet chemotherapy to mFOLFOX for high-risk stage III colon cancer in adjuvant setting | |||||||||||||
Medical condition: High-risk stage III colon cancer in adjuvant setting | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001264-11 | Sponsor Protocol Number: UMCM-2016EPI05 | Start Date*: 2016-09-07 |
Sponsor Name:University Medical Center of the Johannes Gutenberg-University Mainz | ||
Full Title: A phase IV, single-center, randomized, double-blind, placebo-controlled, parallel group study on the effects of empagliflozin on left ventricular diastolic function compared to usual care in indivi... | ||
Medical condition: Poorly controlled type 2 diabetes mellitus in adults | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-007813-35 | Sponsor Protocol Number: TBA | Start Date*: 2008-06-16 | |||||||||||
Sponsor Name:University Hospital of North Tees and Hartlepool | |||||||||||||
Full Title: Randomised Controlled Trial of the Use of Topical Application of Tranexamic Acid in Primary Cemented Total Knee Replacement (TRANX-K). | |||||||||||||
Medical condition: In this study Tranexamic acid efficacy in reducing blood loss will be investigated in total knee replacement.Tranexamic acid will be applied topically to the exposed tissue around the knee joint pr... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004119-11 | Sponsor Protocol Number: SPECT | Start Date*: 2016-12-19 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: Study on half-dose Photodynamic therapy versus Eplerenone in chronic CenTRAl serous chorioretinopathy (SPECTRA trial) | |||||||||||||
Medical condition: Chronic central serous chorioretinopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003958-94 | Sponsor Protocol Number: CVAH631BDE06 | Start Date*: 2005-12-02 | |||||||||||
Sponsor Name:Novartis Phama GmbH | |||||||||||||
Full Title: A randomized, open-label, multicenter, cross-over trial to evaluate the efficacy of a 20 week treatment of Valsartan 320 mg (Diovan) versus Atenolol 100 mg in combination with Hydrochlorothiazide o... | |||||||||||||
Medical condition: Essential mild-to-moderate hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010384-16 | Sponsor Protocol Number: C09-1 | Start Date*: 2009-04-10 | |||||||||||
Sponsor Name:GERCOR | |||||||||||||
Full Title: A Phase III randomized trial investigating the duration of adjuvant therapy with the modified FOLFOX 6 regimen (3 versus 6 months) for patients with stage III colon cancer. | |||||||||||||
Medical condition: Stage III colon cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
